Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2026-01-13 @ 3:42 AM
Study NCT ID:
NCT03141203
Status:
COMPLETED
Last Update Posted:
2022-05-18
First Post:
2017-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients
Sponsor:
University of Birmingham
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Peripheral T Cell Lymphoma | View |
Keywords: